Overcoming Immunological Resistance Enhances the Efficacy of a Novel anti-tMUC1 CAR T Cell Treatment Against Pancreatic Ductal Adenocarcinoma
Mahboubeh Yazdanifar(Stanford University), Pinku Mukherjee(University of North Carolina at Charlotte)
Cited by 22
Related Papers
MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes
|Oncogenesis|2013|174
CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies
|Stem Cell Research & Therapy|2021|76
RETRACTED: A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions
|Frontiers in Immunology|2021|48
Reconstructing the cell–cell interaction network among mouse immune cells
|Biotechnology and Bioengineering|2023|15